Miquel Bioque

3.4k total citations
96 papers, 1.9k citations indexed

About

Miquel Bioque is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Clinical Psychology. According to data from OpenAlex, Miquel Bioque has authored 96 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Psychiatry and Mental health, 25 papers in Biological Psychiatry and 14 papers in Clinical Psychology. Recurrent topics in Miquel Bioque's work include Schizophrenia research and treatment (54 papers), Bipolar Disorder and Treatment (32 papers) and Tryptophan and brain disorders (25 papers). Miquel Bioque is often cited by papers focused on Schizophrenia research and treatment (54 papers), Bipolar Disorder and Treatment (32 papers) and Tryptophan and brain disorders (25 papers). Miquel Bioque collaborates with scholars based in Spain, United States and Italy. Miquel Bioque's co-authors include Miquel Bernardo, Mara Parellada, Bibiana Cabrera, Ana González‐Pinto, Juan C. Leza, Eduard Parellada, António Lobo, Borja García‐Bueno, Clemente García‐Rizo and Celso Arango and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Miquel Bioque

86 papers receiving 1.9k citations

Peers

Miquel Bioque

PMH

PHARM

Clemente García‐Rizo Spain

Richard Musil Germany

Olli Kampman Finland

Michael Obermeier Germany

Marina Šagud Croatia

Jogin H. Thakore United Kingdom

Eduard Parellada Spain

Rune A. Kroken Norway

Ilja Spellmann Germany

Fernando Caravaggio Canada

Clemente García‐Rizo Spain

Miquel Bioque

1.3k ×1.2

PMH

526 ×0.9

125 ×0.5

PHARM

355 ×1.5

251 ×1.1

Citations per year, relative to Miquel Bioque Miquel Bioque (= 1×) peers Clemente García‐Rizo

Countries citing papers authored by Miquel Bioque

Since Specialization

Citations

This map shows the geographic impact of Miquel Bioque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miquel Bioque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miquel Bioque more than expected).

Fields of papers citing papers by Miquel Bioque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miquel Bioque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miquel Bioque. The network helps show where Miquel Bioque may publish in the future.

Co-authorship network of co-authors of Miquel Bioque

This figure shows the co-authorship network connecting the top 25 collaborators of Miquel Bioque. A scholar is included among the top collaborators of Miquel Bioque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miquel Bioque. Miquel Bioque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giménez‐Palomo, Anna, et al.. (2024). Maintenance Electroconvulsive Therapy in Catatonia. Journal of Ect. 40(3). 173–176. 1 indexed citations

Bioque, Miquel, Jordi Rumià, Pedro Roldán, et al.. (2023). Deep brain stimulation and digital monitoring for patients with treatment-resistant schizophrenia and bipolar disorder: A case series. PubMed. 18(1). 13–16. 3 indexed citations

Pujol, Núria, Daniel Bergé, Anna Mané, et al.. (2022). The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study. Psychiatry Research. 316. 114760–114760. 2 indexed citations

Mezquida, Gisela, Patricia Gassó, Natàlia Rodríguez, et al.. (2022). Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. Psychological Medicine. 53(10). 4634–4647. 7 indexed citations

Hidalgo‐Figueroa, María, Alejandro Salazar, Cristina Romero-López-Alberca, et al.. (2022). The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance. The International Journal of Neuropsychopharmacology. 25(8). 666–677. 13 indexed citations

Gich, Ignasi, et al.. (2021). High neutrophil-lymphocyte ratio upon admission is associated with better response in psychotic depression. Journal of Psychiatric Research. 143. 38–42. 11 indexed citations

Verdolini, Norma, Sílvia Amoretti, Gisela Mezquida, et al.. (2021). The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years. European Neuropsychopharmacology. 49. 54–68. 12 indexed citations

Ballesteros, Alejandro, Ana M. Sánchez-Torres, Jose M. López-Ilundain, et al.. (2020). The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory. Psychological Medicine. 51(12). 2044–2053. 8 indexed citations

Gassó, Patricia, Joan Albert Arnáiz, Sergi Mas, et al.. (2020). Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period. Journal of Psychopharmacology. 34(5). 514–523. 13 indexed citations

10.

Vázquez-Bourgón, Javier, Marcos Gómez‐Revuelta, María Juncal‐Ruíz, et al.. (2020). Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort. The International Journal of Neuropsychopharmacology. 24(1). 1–7. 14 indexed citations

11.

Amoretti, Sílvia, Adriane Ribeiro Rosa, Gisela Mezquida, et al.. (2020). The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses. Psychological Medicine. 52(3). 526–537. 19 indexed citations

12.

Bioque, Miquel, Sergi Mas, Maria C. Costanzo, et al.. (2019). Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis. European Neuropsychopharmacology. 29(6). 786–794. 15 indexed citations

13.

Penadés, Rafael, Marta Bosia, Rosa Catalán, et al.. (2019). The role of genetics in cognitive remediation in schizophrenia: A systematic review. Schizophrenia Research Cognition. 19. 100146–100146. 8 indexed citations

14.

Bioque, Miquel & Miquel Bernardo. (2018). The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia. Expert Opinion on Pharmacotherapy. 19(14). 1623–1629. 9 indexed citations

15.

Gassó, Patricia, Sergi Mas, Miquel Bioque, et al.. (2018). Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis. Journal of Psychopharmacology. 32(6). 702–710. 6 indexed citations

16.

Bernardo, Miquel, Miquel Bioque, Bibiana Cabrera, et al.. (2017). Modelling gene-environment interaction in first episodes of psychosis. Schizophrenia Research. 189. 181–189. 39 indexed citations

17.

Bernardo, Miquel & Miquel Bioque. (2016). Three-month paliperidone palmitate - a new treatment option for schizophrenia. Expert Review of Clinical Pharmacology. 9(7). 899–904. 9 indexed citations

18.

Cabrera, Bibiana, Miquel Bioque, Rafael Penadés, et al.. (2016). Cognition and psychopathology in first-episode psychosis: are they related to inflammation?. Psychological Medicine. 46(10). 2133–2144. 35 indexed citations

19.

Catalán, Rosa, Alexandre González-Rodríguez, Rafael Penadés, et al.. (2015). Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review. Patient Preference and Adherence. 9. 695–695. 24 indexed citations

20.

Bioque, Miquel, Borja García‐Bueno, Karina S. MacDowell, et al.. (2013). Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis. Neuropsychopharmacology. 38(13). 2568–2577. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact